Molecular Partners AG -ADRMOLN
13F holders, Q1 2024 (March 31)8holders
$4.05avg. 13F price*
At the end of Q1 2024, 8 institutions reported holding Molecular Partners AG -ADR (MOLN) in their 13F filings. The largest holders were BVF Inc. ($1.7M), Montanova Capital, LLC ($1.7M) and Tang Capital Management LLC ($420K).
- Company
- Molecular Partners AG -ADR
- CUSIP
- 60853G106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $7K |
| Exits | 2 | $50K |
Ownership 8 holders
| BVF Inc. | 0.05% | No change | 443,221 | $1.7M |
| Montanova Capital, LLC | 0.07% | No change | 400,000 | $1.7M |
| Tang Capital Management LLC | 0.04% | No change | 100,000 | $420K |
| Royal Bank of Canada | 0.00% | New | 1,500 | $6K |
| Morgan Stanley | 0.00% | No change | 367 | $1K |
| UBS Group AG | 0.00% | New | 326 | $1K |
| Rhumbline Advisers | 0.00% | No change | 269 | $1K |
| Qube Research & Technologies Ltd | 0.00% | No change | 16 | $62 |
"% of holder's portfolio" is MOLN's weight in each manager's 13F, not the share of Molecular Partners AG -ADR the manager owns.